About
Provided by Baker Botts L.L.P.
Baker Botts has a nationally recognized and ranked M&A practice, with over 50 partners who have a significant M&A practice. Over the last five years, our lawyers have worked on nearly 500 M&A transactions in excess of $500 billion around the world, for over 250 different clients.
Our team has advised strategic buyers and sellers on leading tech M&A transactions, including corporate reorganizations, spin-offs and split-offs, joint development, joint ventures, strategic alliances, and opportunistic, distressed and/or bankruptcy-related acquisitions and dispositions. These transactions often involve commercial licensing, and supply, marketing, and distribution arrangements for critical or innovative technology. Our extensive experience in Silicon Valley and cross-border tech M&A transactions helps us see around corners, give practical advice, and help clients achieve optimal results in an expedited fashion. Clients benefit from our lawyers’ experience serving in legal leadership positions at prominent tech companies such as Tesla, Liberty Media Corporation, Texas Instruments, Spectra 7 Microsystems and Sterling Software. We bring technical depth through collaboration with our nationally ranked intellectual property group, with attorneys with 240+ scientific and technical degrees, including 20 PhDs.
To learn more about our practice, please visit: https://www.bakerbotts.com/services/industries/technology/technology-media-and-entertainment-tme
Chambers Review
Baker Botts L.L.P. has an experienced technology team with a fine track record in M&A and capital markets transactions. Regularly engaged to advise on regulatory compliance issues and corporate governance matters. Frequently represents clients in the telecommunications and energy tech industries on licensing and development arrangements. Fields additional expertise in matters pertaining to the pharmaceutical, life sciences and media sectors. The firm provides ancillary support in handling cybersecurity and data privacy issues.
Samantha Hale Crispin is a key contact.
Work Highlights
- Baker Botts L.L.P. advised Novartis Pharmaceuticals on technology transfer and manufacturing arrangements with Janssen Research & Development and Legend Biotech for the clinical manufacturing of next-generation cancer treatments.
Members
Provided by Baker Botts L.L.P.